Bupivacaine Baxter

Medicinal product

(Invented) name

Bupivacaine Baxter

Active substance (s)

Bupivakaino hidrochloridas

Strength

5 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į epidurinę ertmę, leisti aplink nervus, leisti į sąnarį, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

N01BB01, Bupivacaine

Marketing authorisation holder

Baxter Holding B.V. , Nyderlandai

Date of authorisation

2010-03-05

Date of renewal

2018-02-26

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/1441/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Bupivakaino hidrochloridas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
29104	31612	1031612	flakonas	10 ml N5	Receptinis	LT/1/10/1886/003	Netiekiama	-	-	No	-	-	Download
39703	53402	1053402	flakonas	20 ml N1	Receptinis	LT/1/10/1886/004	Netiekiama	-	-	No	-	-
62455	76863	1076863	flakonas	10 ml N10	Receptinis	LT/1/10/1886/006	Netiekiama	-	-	No	-	-
100279	86388	1086388	flakonas	20 ml N5	Receptinis	LT/1/10/1886/007	Netiekiama	-	-	No	-	-
100280	86389	1086389	flakonas	20 ml N10	Receptinis	LT/1/10/1886/008	Netiekiama	-	-	No	-	-

Stadijos